- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Telepsychiatry In Dialysis Patients: A Dream Or A Reality?

Telepsychiatry In Dialysis Patients: A Dream Or A Reality?
Depression is the most common mental health illness in patients with kidney failure. The reported prevalence of depression in the dialysis population varies widely and can be as high as approximately 40%.1 Join us for a conversation with Dr Shirazian and Dr Behrens as we explore the utility of telepsychiatry in patients undergoing hemodialysis, potential barriers, and the importance of addressing mental health in patients with chronic kidney disease.Please note: Due to high levels of interest, please access this webinar via your computer.
Reference
1 King-Wing Ma T, Kam-Tao Li P. Depression in dialysis patients. Nephrology. 2016 Aug;21(8):639-46.
*Drs Shayan Shirazian and Jake Behrens are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Tazin Aijaz is an employee of OPDC.
Featuring
-
Shirazian Shayan, MD
Assistant Professor of Medicine, Division of Nephrology
-
Jake Behrens, MD
CEO & Medical Director, Regional Director Envision ADHD, Brightside Health
-
Aijaz Tazin, PharmD, BCPS
Nephrology Senior Medical Science Liaison Otsuka Pharmaceutical Development & Commercialization, Inc.*
Related Events
Register
This event registration is closed.